| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000049423 |
| Receipt No. | R000056275 |
| Scientific Title | Confirmation test of skin improvement effect by 3-month ingestion of beauty supplements containing herbal medicines-3 |
| Date of disclosure of the study information | 2025/01/01 |
| Last modified on | 2022/11/04 (Ver. 1) |
| Basic information | ||
| Public title | Confirmation test of skin improvement effect by 3-month ingestion of beauty supplements containing herbal medicines-3 | |
| Acronym | Confirmation test of skin improvement effect by 3-month ingestion of beauty supplements containing herbal medicines-3 | |
| Scientific Title | Confirmation test of skin improvement effect by 3-month ingestion of beauty supplements containing herbal medicines-3 | |
| Scientific Title:Acronym | Confirmation test of skin improvement effect by 3-month ingestion of beauty supplements containing herbal medicines-3 | |
| Region |
|
|
| Condition | |||
| Condition | Healthy person | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | Confirm the effect of improving skin condition, mainly skin elasticity, when taking the test product for 3 months |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Skin elasticity (probe 6mm) |
| Key secondary outcomes | *Secondary index
[1] Skin elasticity (probe 2mm) [2] Wrinkle evaluation value by doctors [3]Questionnaire of physical feeling *Safety [1]Doctor's questions *Other index [1]Subject's diary |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Ingestion of test food containing plant mixed extract A and plant mixed extract B (Tablets) for 12 weeks | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | 1. Those who indicate their intention to participate in the test, understand the explanation, and obtain written consent to participate in the test
2. Healthy Japanese women between the ages of 35 and 50 who do not meet the exclusion criteria 3. Those who can fill in documents such as consent forms, questionnaires, test product intake diaries, etc. 4. Subjects who have felt effects on the skin with supplements, etc. 5. Subjects who feel a decrease in skin firmness 6. Mainly Grade 1 to 3 on the outer corner of the eye (Journal of the Japanese Cosmetic Science Society, 2006, Vol. 30, No. 4) Persons with wrinkles corresponding to p316-322) 7. People with dry skin 8. Those who have menopausal symptoms (any symptoms) Flushed face, sweating easily, lower back and limbs getting cold easily, shortness of breath/palpitations, difficulty falling asleep/shallow sleep, irritability and irritability, drowsiness/depression, headache/dizziness/nausea are common , Stiff shoulders, back pain, pain in limbs 9. Those who feel easily tired |
|||
| Key exclusion criteria | Those who meet even one of the following conditions will be excluded.
1. Those who currently use skin care and diet supplements, collagen supplements, and pharmaceuticals on a regular basis 2. Persons who cannot abstain from drinking from the day before the measurement to the end of the measurement 3. Those who smoke on a daily basis 4. Person with asthma 5. Those who are pregnant or planning to become pregnant, those who are breastfeeding 6. Those who have hay fever (those who do not take hay fever medicine are allowed) 7. Persons with food allergies 8. Tests of ingesting other foods and drugs, and applying cosmetics and drugs who are currently participating in a similar study or who have been participating in a similar study for at least 3 months who have not passed 9. Others who are judged to be inappropriate by the principal investigator |
|||
| Target sample size | 25 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Shiseido Co., Ltd. | ||||||
| Division name | MIRAI Technology Institute | ||||||
| Zip code | 220-0011 | ||||||
| Address | 1-2-11, Takashima, Nishi-ku, Yokohama-shi, Kanagawa, Japan | ||||||
| TEL | 045-222-1600 | ||||||
| osamu.ueda@shiseido.com | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Inforward Co., Ltd. | ||||||
| Division name | Ebisu Skin Research Center | ||||||
| Zip code | 150-0013 | ||||||
| Address | 5th floor, 1-11-2 Ebisu, Shibuya-ku, Tokyo | ||||||
| TEL | 03-5793-8712 | ||||||
| Homepage URL | |||||||
| sakurai@inforward.co.jp | |||||||
| Sponsor | |
| Institute | Shiseido Co., Ltd. |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Shiseido Co., Ltd. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | General Incorporated Association Crinical Rese arch Review Center |
| Address | 2972-8-603 Ishikawamachi Hachioji-shi,Toky o,192-0032,JAPAN |
| Tel | 090-3547-6398 |
| crrctakashima@kpd.biglobe.ne.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB | |||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000056275 |